Retention of testing sample [Regulatives / Guidelines]

posted by gracehung – Taiwan, 2014-02-11 12:44 (4519 d 04:33 ago) – Posting: # 12393
Views: 1,601

Dear all,

After completion of clinical trial, could we send the retention samples from trial site back to CRO who conduct project management, bioanalysis, PK/statistical analysis and issue final report? And could we retain the reserve samples in CRO?
According to FDA guideline, the reserve samples should not send back to the study sponsor or drug manufacturer. Could we look on the CRO as a independent third party?

Best Regards,

Grace

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
365 visitors (0 registered, 365 guests [including 10 identified bots]).
Forum time: 18:18 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5